Director
H. Edward Fleming, Jr., M.D.
H. Edward (Edd) Fleming, Jr., M.D., has served on our Board of Directors since June 2021. Since November 2022, he has been Executive Vice President, Commercial, at Enavate Sciences, a biotech venture capital firm focused on investing in and building therapeutic companies. Prior to that, Dr. Fleming spent 25 years at McKinsey & Company (1997–2022), where he held multiple leadership roles, most recently serving as Senior Partner and global leader of the firm’s research and development practice.
He currently serves on the boards of directors of Upstream Bio, Inc. (UPB) and Sionna Therapeutics, Inc. (SION), as well as several private biotechnology companies. He is also a member of the Board of Visitors for Vanderbilt University’s School of Basic Sciences.
Dr. Fleming earned a B.A. in Chemistry from Harvard University and an M.D. from Vanderbilt University. He completed his internal medicine residency at Johns Hopkins Hospital and his subspecialty training in pulmonary and critical care medicine at the University of California, San Francisco.
